Health Trials

Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or Without Allodynia: a Regional Multicenter Prospective Cohort

ConditionPeripheral Neuropathic Pain
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Annecy Genevois

About this trial

Prospective multicenter cohort to determine patient profiles (associated factors, including allodynia) with a better response to pain desensitization by capsaicin delivered in the form of a high concentration patch (8%), in a population of patients with peripheral neuropathic pain and followed up in a pain consultation in the Auvergne Rhône Alpes region.

Eligibility criteria

Qualifiers

Patient over 18 years of age on the day of inclusion

Patient who has been informed and has not expressed opposition to participating in the study,

"Neuropathic Pain 4" score ("DN4" score) ≥ 4/10

AND pain according to the numerical scale (EN) > 4/10,

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Questionnaires

Treatment groups

400 Participants
are divided into 1 treatment group

Sponsors and collaborators

Centre Hospitalier Annecy Genevois

Lead sponsor

Source ClinicalTrials.gov